Advances toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 3 - Concepedia

Concepedia

Publication | Closed Access

Advances toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 3

20

Citations

10

References

2003

Year

Kumiko Takeuchi, Todd J. Kohn, Nicholas A Honigschmidt, Vincent P. Rocco, Patrick Spinazze, Steven T Atkinson, Larry W. Hertel, David L. Nelson, David B. Wainscott, Laura Ahmad,

Bioorganic & Medicinal Chemistry Letters

Molecular PharmacologyNew AntidepressantsPsychoactive DrugPsychiatryFunctional SelectivityPsychotropic MedicationPharmacologyDepressionPsychopharmacologyNeuropharmacologyPharmacological AgentPharmacotherapyMood DisordersBiological PsychiatryMedicineDrug Discovery

References

	Year	Citations

Page 1

Page 1